Now showing items 51-60 of 158
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
(American Society for Microbiology., 2010-01)
HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was ...
Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.
(Oxford University Press for the International Epidemiological Association., 2011-08)
Objective: To determine the HIV incidence rate among rural and urban women in KwaZulu-Natal, South Africa. Methods: We conducted a prospective cohort study from March 2004 to May 2007. Volunteers were recruited from a ...
Screening for ‘window-period’ acute HIV infection among pregnant women in rural South Africa.
(Wiley-Blackwell for British HIV Association., 2010-11)
Objectives. The aim of this study was to evaluate the HIV-1 RNA pooled nucleic acid amplification testing (NAAT) strategy to screen pregnant women in the ‘window period’ of acute HIV infection (AHI) in rural South ...
Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
(Future Medicine., 2010)
No abstract available.
Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for CMV-specific CD8+ T cells.
(American Association of Immunologists., 2012-09-15)
The generation of polyfunctional CD8+ T cells, in response to vaccination or natural infection, has been associated with improved protective immunity. However, it is unclear whether the maintenance of polyfunctionality is ...
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial.
(Lippincott Williams & Wilkins., 2011)
OBJECTIVE: Women who become pregnant during the conduct of biomedical human immunodeficiency virus prevention trials are taken off the study product for safety reasons. High pregnancy rates can compromise statistical ...
HIV pre-exposure prophylaxis in injecting drug users.
No abstract available.
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
(Macmillan Publishers Limited., 2014)
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the developmental pathway by which such ...
Which new health technologies do we need to achieve an end to HIV/AIDS?
(Public Library of Science., 2016)
Abstract available in PDF file.
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.
(American Association for the Advancement of Science., 2017)
Abstract available in pdf.